CORTEXA
← Browse
openalexFrontiers in Cardiovascular Medicine2026-07-24Cited by 0

Interpretable machine learning and mendelian randomization identify risk factors for lower extremity arterial embolism and thrombosis

X J Li, Guohao Wei, Rui Liu, Qiulin Jiang, Yarong Ma, Xiaolei Sun

Background Lower extremity arterial embolism and thrombosis lead to significant morbidity, but their risk factors are not fully characterized. Objectives To identify risk factors and develop an interpretable machine learning (ML) model for predicting lower extremity arterial embolism and thrombosis, with validation using mendelian randomization (MR). Methods In this retrospective case-control study, data were collected from patients with lower extremity arterial embolism and thrombosis treated at our department of vascular surgery between January 2018 and November 2025. Predictors were selected using LASSO regression, and 11 ML models were developed using the selected variables. The optimal model was interpreted and implemented as a web-based prediction tool. Clinical utility and model calibration were assessed using decision curve analysis and calibration curves. Key predictors were further assessed using MR and multivariable logistic regression. Results XGBoost achieved the highest discrimination, with an AUC of 0.951 (95% CI 0.925–0.972) in the test set. MR analyses indicated that genetically predicted cerebrovascular disease (CD) (OR 1.773; 95% CI 1.043–3.015; P = 0.035) and gamma-glutamyl transferase (GGT) (OR 1.327; 95% CI 1.105–1.595; P = 0.003) were risk factors, whereas mean platelet volume (MPV) was protective (OR 0.879; 95% CI 0.778–0.993; P = 0.038). Multivariable logistic regression confirmed CD (OR 10.19; 95% CI 4.36–23.82; P < 0.001) and MPV (OR 0.63; 95% CI 0.52–0.76; P < 0.001) as independent predictors. Conclusions Interpretable ML combined with MR identified a history of CD and lower MPV as factors associated with risk of lower extremity arterial embolism and thrombosis.

View free PDFSource page

Related papers

openalexFrontiers in Cardiovascular Medicine2026-07-24

Clinical relevance of circulating endocan and endoglin in excess body weight-associated endothelial dysfunction

Charu Sharma, Abubaker Suliman, Ali Mohammed Aldhaheri, Saeed Mohammed Alnuaimi, Khaled Mohamed Alderei, Sania Mazin AlHamad, et al.

Introduction Endothelial dysfunction is an early and pivotal event in the development of cardiovascular disease and a key mechanism linked to atherosclerotic plaque formation. Endocan and endoglin are emerging cardiometabolic markers and novel endothelial mediators that promote v…

View free PDFSource page
openalexFrontiers in Cardiovascular Medicine2026-07-24

Five-year cardiovascular outcomes across hypertensive disorders of pregnancy subtypes: a propensity-matched analysis

Laith Alhuneafat, Omar Obeidat, Dina Mohammed, Nikita Sumzin, Kamel Ikbariah, Ahmad Al‐Abdouh, et al.

Background Hypertensive disorders of pregnancy (HDP) are established risk factors for future cardiovascular disease, yet long-term cardiovascular risk across specific HDP subtypes remains incompletely defined. Methods We conducted a retrospective cohort study using a large, globa…

View free PDFSource page
openalexFrontiers in Cardiovascular Medicine2026-07-24

Case Report: Shared decision-making in severe rheumatic mitral stenosis complicating pregnancy

Luis Armando Velásquez Trujillo, Manuel Alejandro Hurtado Rivera, V. Enriquez, Sebastián Ayala Zapata, Stephany Barbosa Balaguera, Álvaro Andrés Herrera Escandón

Severe rheumatic mitral stenosis (MS) is one of the highest-risk valvular lesions in pregnancy, and it becomes particularly hard to manage when the valve is unsuitable for percutaneous balloon mitral valvuloplasty (PBMV) and the patient declines termination. We describe a 20-year…

View free PDFSource page
openalexFrontiers in Cardiovascular Medicine2026-07-24

Urinary nephrin as an early biomarker of podocyte dysfunction in essential hypertension: a stage-stratified study from Bukhara, Uzbekistan

Mukhammad Komil ogli Amonov

Essential hypertension is a leading cause of chronic kidney disease, but conventional renal markers detect injury only after substantial nephron loss. Urinary nephrin, a slit-diaphragm protein released during podocyte injury, has been proposed as an early biomarker of hypertensiv…

View free PDFSource page
openalexFrontiers in Cardiovascular Medicine2026-07-24

A deep learning model for the interpretable identification of pulmonary thromboembolism from computed tomography pulmonary angiography

Y Li, Sunyu Chen, Guangkun Chen, Baosheng Ren, 胡仕兵, Min Zong, et al.

Objective The rapid identification of pulmonary thromboembolism (PTE) on computed tomography pulmonary angiography (CTPA) is vital but labor-intensive, often leading to diagnostic delays. We aimed to construct and evaluate a YOLOv11 object detection algorithm capable of automatic…

View free PDFSource page
openalexFrontiers in Cardiovascular Medicine2026-07-23

Genetic liability to childhood Kawasaki disease and adult cardiovascular outcomes

Mengzhuo Wang, Sha Lin, Xiaoliang Liu, Jinlin Wu, Yifei Li

Background Kawasaki disease (KD) occurring in childhood has been epidemiologically associated with increased adult cardiovascular risk, particularly in children who develop coronary aneurysms during the acute phase. However, the causal nature of this association remains uncertain…

View free PDFSource page